AMGN Sentiment Analysis
We collect and analyze sentiment surrounding AMGN stock to help you make informed investment decisions.
Amgen Inc. AMGN Sees Significant Drop in Short Interest
Published on November 22, 2024
Amgen Inc....
Amgen Inc. AMGN Shows Strong Growth Potential Despite Earnings Decline
Published on November 21, 2024
Amgen Inc. (AMGN) has caught the attention of investors as a trending stock with a promising future....
Amgen Inc. AMGN Reported to Be the Leader in Immunotherapy
Published on November 21, 2024
Amgen Inc. (NASDAQ: AMGN) has emerged as the top player in the field of immunotherapy, according to recent reports....
Amgen Inc. AMGN Witnesses a Significant Drop in Short Interest: A Promising Trend to Invest In
Published on November 20, 2024
Amgen Inc....
Amgen Inc. AMGN: Revolutionizing the Biopharmaceutical Industry
Published on November 19, 2024
Amgen Inc., a leading biopharmaceutical company, is making waves in the industry with its innovative research and development....
Amgen Inc: A Leading Biotechnology Company with Promising Opportunities for Investors
Published on November 19, 2024
Amgen Inc, also known as AMGN, is a renowned biotechnology company that has been capturing the attention of investors worldwide. With its diverse portfolio of innovative drugs, Amgen Inc has established itself as a leader in the industry. One of the ...
AMGEN ALERT: Bragar Eagel Squire P.C. is Investigating Amgen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published on November 16, 2024
Bragar Eagel Squire P.C., a renowned law firm, has initiated an investigation into Amgen Inc....
Amgen Inc.: Is Wall Street Bullish or Bearish on Amgen Stock?
Published on November 15, 2024
In recent weeks, there has been much debate on Wall Street about the future of Amgen Inc. (NASDAQ:AMGN) stock....
Amgen stock rebounds after addressing MariTide concerns
Published on November 14, 2024
Amgen Inc....
Amgen stock gains as MariTide concerns addressed AMGN:NASDAQ
Published on November 13, 2024
Shares of Amgen Inc. (NASDAQ:AMGN) saw a boost in trading after the company addressed concerns regarding its MariTide drug....
Amgen Inc. Faces Risks with Obesity Drug, Causing Stock to Slip
Published on November 12, 2024
Amgen Inc. (NASDAQ: AMGN) recently faced a setback as safety concerns emerged regarding their obesity candidate drug....
Amgen Inc. (AMGN) Sees Major Increase in Investor Interest: Here's Why
Published on November 12, 2024
Amgen Inc....
Amgen Inc. AMGN: The Pharma Stock Investors are Searching For
Published on November 11, 2024
Investors have shown a strong interest in Amgen Inc. (AMGN), one of the leading biotechnology companies in the world....
Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN
Published on November 10, 2024
Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN. This move reflects the company's confidence in Amgen's future prospects, despite the recent challenges face...
AMGEN INC. Stock Hits Price Target Forecast with 21.42% Profit Achieved
Published on September 16, 2024
On October 17, 2023, QuantWave, the automated forecasting platform, issued a long signal for AMGEN INC....
AMGEN INC. Stock Hits Price Target Forecast with 20.73% Profit
Published on July 17, 2024
AMGEN INC. (NASDAQ: AMGN) recently achieved the price target forecast set by QuantWave, leading to a profit of 20....
AMGEN INC. Hits QuantWave's Price Target Forecast with 12.91% Profit
Published on July 12, 2024
AMGEN INC. has successfully achieved the price target forecast set by QuantWave, signaling a profitable outcome for investors....
AMGEN INC. Hits Price Target Forecast on QuantWave with 41.07% Profit
Published on February 1, 2024
AMGEN INC....
AMGEN INC. Hits Forecast Price Target with 20.66% Profit Gain — QuantWave Success Story
Published on February 1, 2024
AMGEN INC. has reached its price target forecast as predicted by QuantWave, resulting in a profit of 20....
AMGEN INC. Hits Price Target with 20.59% Profit as Forecasted by QuantWave
Published on February 1, 2024
On October 10, 2023, QuantWave, the automated forecasting platform, issued a long signal for AMGEN INC. with a price target of $309....
AMGEN INC. Hits Price Target Forecast with 21.14% Profit Margin
Published on February 1, 2024
AMGEN INC. has successfully reached the price target forecast set by QuantWave, yielding a profitable return of 21.14%....
AMGEN INC. Hits Price Target Forecast with 22.24% Profit on QuantWave Platform
Published on February 1, 2024
AMGEN INC. has successfully reached the price target forecast set by QuantWave on February 1, 2024, resulting in a 22....
AMGEN INC. Stock Hits Price Target Forecast with 23.49% Profit
Published on February 1, 2024
QuantWave, the automated forecasting platform, successfully predicted a price target for AMGEN INC. stock, resulting in a 23....
AMGEN INC. Hits Price Target Forecast with 41.07% Profit: A Triumph for QuantWave's Analytics
Published on February 1, 2024
On May 2, 2023, QuantWave's forecasting system issued a long signal for AMGEN INC., with the stock trading at 217.83 $....
AMGEN INC. Hits Forecast Price Target with 21.14% Profit Margin
Published on February 1, 2024
AMGEN INC. (AMGN) investors rejoice as the stock hits the forecast price target of $307....